STELEXIS THERAPEUTICS
Stelexis Therapeutics is to become the cancer therapeutics company, through the discovery and development of novel drugs, utilizing its proprietary platform to selectively target pre-cancerous stem cells. The company will initially focus on therapeutics for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
STELEXIS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.stelexis.com
Total Employee:
1+
Status:
Active
Total Funding:
43 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving Global Site Tag
Current Employees Featured
Founder
Investors List
Deerfield Capital Management
Deerfield Capital Management investment in Series A - Stelexis Therapeutics
Deerfield
Deerfield investment in Series A - Stelexis Therapeutics
Official Site Inspections
http://www.stelexis.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 